HK1019878A1 - Total synthesis of antitumor acylfulvenes. - Google Patents

Total synthesis of antitumor acylfulvenes.

Info

Publication number
HK1019878A1
HK1019878A1 HK99105109A HK99105109A HK1019878A1 HK 1019878 A1 HK1019878 A1 HK 1019878A1 HK 99105109 A HK99105109 A HK 99105109A HK 99105109 A HK99105109 A HK 99105109A HK 1019878 A1 HK1019878 A1 HK 1019878A1
Authority
HK
Hong Kong
Prior art keywords
acylfulvenes
antitumor
total synthesis
synthesis
total
Prior art date
Application number
HK99105109A
Other languages
English (en)
Inventor
Trevor C Mcmorris
Original Assignee
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ California filed Critical Univ California
Publication of HK1019878A1 publication Critical patent/HK1019878A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C35/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C07C35/22—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring polycyclic, at least one hydroxy group bound to a condensed ring system
    • C07C35/37—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring polycyclic, at least one hydroxy group bound to a condensed ring system with a hydroxy group on a condensed system having three rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/703—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups
    • C07C49/723—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups polycyclic
    • C07C49/727—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups polycyclic a keto group being part of a condensed ring system
    • C07C49/737—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups polycyclic a keto group being part of a condensed ring system having three rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/93—Spiro compounds
    • C07C2603/94—Spiro compounds containing "free" spiro atoms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/582—Recycling of unreacted starting or intermediate materials
HK99105109A 1996-08-08 1999-11-08 Total synthesis of antitumor acylfulvenes. HK1019878A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/689,461 US5723632A (en) 1996-08-08 1996-08-08 Total synthesis of antitumor acylfulvenes
PCT/US1997/013644 WO1998005669A1 (en) 1996-08-08 1997-08-05 Total synthesis of antitumor acylfulvenes

Publications (1)

Publication Number Publication Date
HK1019878A1 true HK1019878A1 (en) 2000-03-03

Family

ID=24768581

Family Applications (1)

Application Number Title Priority Date Filing Date
HK99105109A HK1019878A1 (en) 1996-08-08 1999-11-08 Total synthesis of antitumor acylfulvenes.

Country Status (12)

Country Link
US (6) US5723632A (US06252093-20010626-C00030.png)
EP (2) EP0918776B1 (US06252093-20010626-C00030.png)
JP (1) JP4267702B2 (US06252093-20010626-C00030.png)
AT (1) ATE263771T1 (US06252093-20010626-C00030.png)
AU (1) AU3744397A (US06252093-20010626-C00030.png)
CA (1) CA2262648A1 (US06252093-20010626-C00030.png)
DE (1) DE69728544T2 (US06252093-20010626-C00030.png)
DK (1) DK0918776T3 (US06252093-20010626-C00030.png)
ES (1) ES2215234T3 (US06252093-20010626-C00030.png)
HK (1) HK1019878A1 (US06252093-20010626-C00030.png)
PT (1) PT918776E (US06252093-20010626-C00030.png)
WO (1) WO1998005669A1 (US06252093-20010626-C00030.png)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5932553A (en) * 1996-07-18 1999-08-03 The Regents Of The University Of California Illudin analogs useful as antitumor agents
US5723632A (en) 1996-08-08 1998-03-03 Mgi Pharma, Inc. Total synthesis of antitumor acylfulvenes
US7141603B2 (en) * 1999-02-19 2006-11-28 The Regents Of The University California Antitumor agents
US6025328A (en) * 1998-02-20 2000-02-15 The Regents Of The University Of California Antitumor agents
US6635490B1 (en) * 2000-05-25 2003-10-21 Noble Laboratories Procedure for the simultaneous quantitative and qualitative analysis of both flavonoid glycosides and steroidal glycosides
ATE469907T1 (de) * 2000-10-02 2010-06-15 Univ Emory Triptolid-analoga zur behandlung von autoimmunkranheiten und entzündungen
US6436916B1 (en) 2000-10-12 2002-08-20 Alvin Guttag Ibuprofen-aspirin and hydroxymethylacylfulvene analogs
US7015247B2 (en) * 2000-10-12 2006-03-21 Alvin Guttag Ibuprofen-aspirin, hydroxymethylacylfulvene analogs and L-sugar illudin analogs
DE60238256D1 (de) * 2001-06-22 2010-12-23 Borealis Tech Oy Metallocenkatalysatoren mit einer in 4-, 5-, 6- oder 7-stellung mit siloxy oder germyloxy substitutierten indenylgruppe
US7718385B2 (en) * 2003-10-17 2010-05-18 The Johns Hopkins University Bioactivation of alkylating agents for cancer treatment
WO2007019308A2 (en) * 2005-08-03 2007-02-15 The Regents Of The University Of California Illudin analogs useful as anticancer agents
WO2008044045A1 (en) 2006-10-12 2008-04-17 Astex Therapeutics Limited Pharmaceutical combinations
US8916552B2 (en) 2006-10-12 2014-12-23 Astex Therapeutics Limited Pharmaceutical combinations
CA2685726A1 (en) * 2007-05-03 2008-11-13 Emory University Fulvene and fulvalene analogs and their use in treating cancers
GB0715576D0 (en) * 2007-08-09 2007-09-19 Syngenta Ltd Novel herbicides
WO2009089285A2 (en) * 2008-01-07 2009-07-16 Emory University Branched diepoxide compounds for the treatment of inflammatory disorders
US11135182B2 (en) 2014-04-10 2021-10-05 Af Chemicals, Llc Affinity medicant conjugates
US10285955B2 (en) 2014-04-10 2019-05-14 Af Chemicals, Llc Affinity medicant conjugate
CN106458922A (zh) 2014-04-10 2017-02-22 Af化学药品有限责任公司 亲和药物共轭物
CN104650160A (zh) * 2015-01-13 2015-05-27 济南大学 卡培他滨关键中间体1,2,3-o-三乙酰基-5-脱氧-d-核糖的合成新方法
EP3846791A4 (en) * 2018-09-04 2022-06-08 Lantern Pharma Inc. ILLUDIN ANALOGUES, THEIR USES AND PROCEDURES FOR THEIR SYNTHESIS
US11160807B1 (en) 2018-12-11 2021-11-02 Af Chemicals, Llc Methods, compositions and devices for treating cancer with illudofulvenes
US11591295B2 (en) 2019-11-25 2023-02-28 Af Chemicals Llc Affinity illudofulvene conjugates

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4559157A (en) * 1983-04-21 1985-12-17 Creative Products Resource Associates, Ltd. Cosmetic applicator useful for skin moisturizing
LU84979A1 (fr) * 1983-08-30 1985-04-24 Oreal Composition cosmetique ou pharmaceutique sous forme aqueuse ou anhydre dont la phase grasse contient un polyether oligomere et polyethers oligomeres nouveaux
US4612302A (en) * 1983-11-14 1986-09-16 Brigham And Women's Hospital Clinical use of somatostatin analogues
US4684620A (en) * 1984-09-04 1987-08-04 Gibson-Stephens Neuropharmaceuticals, Inc. Cyclic polypeptides having mu-receptor specificity
JPS62234040A (ja) * 1986-04-02 1987-10-14 Kyowa Hakko Kogyo Co Ltd Ｄｃ１０４３物質
US4853371A (en) * 1986-06-17 1989-08-01 The Administrators Of The Tulane Educational Fund Therapeutic somatostatin analogs
US4820508A (en) * 1987-06-23 1989-04-11 Neutrogena Corporation Skin protective composition
US4992478A (en) * 1988-04-04 1991-02-12 Warner-Lambert Company Antiinflammatory skin moisturizing composition and method of preparing same
US4938949A (en) * 1988-09-12 1990-07-03 University Of New York Treatment of damaged bone marrow and dosage units therefor
US5439936A (en) * 1989-10-03 1995-08-08 The Regents Of The University Of California Method of treating certain tumors using illudin analogs
DE69028320T2 (de) * 1989-10-03 1997-03-06 Univ California Illudin-analoge, verwendet als antitumormittel
GB9017024D0 (en) * 1990-08-03 1990-09-19 Erba Carlo Spa New linker for bioactive agents
SI9400195B (sl) * 1993-04-27 2003-10-31 Smithkline Beecham Corporation Antagonisti endotelinskih receptorjev
US5708163A (en) * 1994-03-15 1998-01-13 Sloan-Kettering Institute Of Cancer Research Synthesis of the breast tumor-associated antigen defined by monoclonalantibody MBRL and uses thereof
US6303120B1 (en) * 1994-03-15 2001-10-16 Memorial Sloan-Kettering Institute For Cancer Research Synthesis of glycoconjugates of the lewis y epitope and uses thereof
US5932553A (en) * 1996-07-18 1999-08-03 The Regents Of The University Of California Illudin analogs useful as antitumor agents
US5723632A (en) * 1996-08-08 1998-03-03 Mgi Pharma, Inc. Total synthesis of antitumor acylfulvenes
US6025328A (en) 1998-02-20 2000-02-15 The Regents Of The University Of California Antitumor agents

Also Published As

Publication number Publication date
US6717017B2 (en) 2004-04-06
EP0918776A1 (en) 1999-06-02
US20030050495A1 (en) 2003-03-13
EP1454890A2 (en) 2004-09-08
AU3744397A (en) 1998-02-25
ATE263771T1 (de) 2004-04-15
US5856580A (en) 1999-01-05
CA2262648A1 (en) 1998-02-12
ES2215234T3 (es) 2004-10-01
DE69728544T2 (de) 2004-09-16
US20010029303A1 (en) 2001-10-11
WO1998005669A1 (en) 1998-02-12
JP4267702B2 (ja) 2009-05-27
EP1454890A3 (en) 2004-11-10
US5723632A (en) 1998-03-03
PT918776E (pt) 2004-07-30
JP2000515552A (ja) 2000-11-21
EP0918776B1 (en) 2004-04-07
US6252093B1 (en) 2001-06-26
DE69728544D1 (de) 2004-05-13
EP1454890A8 (en) 2004-11-03
US6160184A (en) 2000-12-12
US6469184B2 (en) 2002-10-22
DK0918776T3 (da) 2004-07-12

Similar Documents

Publication Publication Date Title
HK1019878A1 (en) Total synthesis of antitumor acylfulvenes.
BE2018C008I2 (US06252093-20010626-C00030.png)
HK1001963A1 (en) Use of compounds in the preparation of a medicament for the inhibition of a pathological condition
HUT66660A (en) Intermediates for producing 9-[(substituted glicyl)-amido]-6-demetyl-6-deoxy-tetracyclines and pharmaceutical compositions containing them
AU4523797A (en) Atherosclerosis treatment
GR3031781T3 (en) Antifungal sordaridin derivatives
PE34996A1 (es) Nuevo derivado de pirrocarbazol
DE69529619D1 (en) Pyrimidinylpyrazolderivate
BG104569A (en) Substituted 2-benzylamino-2-phenyl-acetamide compounds
AU7872798A (en) 16-ene-vitamin D derivatives
EP0924199A4 (US06252093-20010626-C00030.png)
EP1034783A4 (en) AMIDE DERIVATIVES
EP0850646A4 (en) LIPOSOMAL PREPARATIONS OF INDOLOCARBAZOLE DERIVATIVES
DE69612967D1 (en) Optisch aktive thiazolidinonderivate
AU3285000A (en) 22r-hydroxycholesta-8,14-diene derivatives for the inhibition of meiosis
IL131380A0 (en) The use of a compound for the manufacture of a pharmaceutical preparatin for the treatment or prevention of prostate cancer
BG104037A (en) 6-pyrrolidin-2-ylpyrindine derivatives, their preparation and application in therapy
BG102429A (en) Derivatives of 5-naphthalen-1-yl-1,3-dioxan, their preparation and usage as therapeutical means
EP0443474A3 (en) 1-phenoxycarbonyl-2-pyrrolidinone derivatives and nootropic agents
AU6943796A (en) Compounds UCH 15

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20100805